Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7488451 | 0.84 | KDM4E (0.52) | KDM4EALDH1A1 | |
| SCHEMBL7492292 | 0.77 | KDM4E (0.50) | KDM4EALDH1A1 | |
| SCHEMBL7496616 | 0.74 | KDM4E (0.62) | KDM4EALDH1A1 | |
| SCHEMBL7489877 | 0.74 | KDM4E (0.45) | KDM4EALDH1A1 | |
| SCHEMBL7484334 | 0.74 | KDM4E (0.49) | KDM4EALDH1A1 | |
| SCHEMBL7484498 | 0.73 | KDM4E (0.54) | KDM4EALDH1A1 | |
| SCHEMBL7487898 | 0.72 | KDM4E (0.50) | KDM4EALDH1A1 | |
| SCHEMBL7488966 | 0.72 | ADRA1D (0.42) | KDM4EALDH1A1 | |
| SCHEMBL7493695 | 0.71 | KDM4E (0.42) | KDM4EALDH1A1 | |
| SCHEMBL7487726 | 0.71 | KDM4E (0.46) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0966466-A1 | PYRROLO 3,2-c]QUINOLINE DERIVATIVES CONTAINING HALOALKOXY GROUP AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1999-12-29 | — | — | EP | disclosed |
| WO-1999009029-A1 | PYRROLO[3,2-c]QUINOLINE DERIVATIVES CONTAINING HALOALKOXY GROUP AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1999-02-25 | — | — | WO | disclosed |